Results for Allergan Plc

Add to feed Create your own feed

Most relevant

At the @US_FDA ’s request, Allergan plc agreed to recall its Biocell textured breast implants and tissue expanders due to an increased risk of breast implant–associated anaplastic large cell lymphoma (BIA-ALCL)—a type of non-Hodgkin lymphoma

tweet picture

Allergan Plc cited concerns over a rare form of cancer, after the U.S. health agency asked the drugmaker to pull the products.

AbbVie Inc. has agreed to pay $63 billion for rival drugmaker Allergan Plc, the latest huge merger in a pharmaceutical sector rapidly being reshaped by deals

AstraZeneca PLC Passes Off Another Amgen-Partnered Drug Candidate in $1.5 Billion Deal With Allergan:   Life ...

BIOGEN HAS DRAWN TAKEOVER INTEREST FROM DRUG COMPANIES INCLUDING MERCK & CO AND ALLERGAN PLC- WSJ

Allergan Plc Q4 15 results: Adj EPS came in at $3.41 (est $3.35); with Revenue of $4.2B (est $4.20B) $AGN

BREAKING: Teva to buy Allergan Plc's generic drugs unit for $40.5 billion

tweet picture

#BREAKING: Allergan reaches friendly deal to be acquired by Actavis PLC, trumping hostile offer by Quebec-based Valeant Pharmaceuticals.

Loading
Loading